UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Correlation between overall survival and quality of life in colon cancer patients with chemotherapy

BMC cancer, 2023-05, Vol.23 (1), p.492-492, Article 492

2023

Volltextzugriff (PDF)

Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan

BMC palliative care, 2019-06, Vol.18 (1), p.45-45, Article 45

2019

Volltextzugriff (PDF)

Phase II Study of the Reuse of Trastuzumab with Docetaxel beyond Progression after First-Line Treatment in Second-Line Treatment for Unresectable, Metastatic Gastric Cancer (T-CORE1203)

The Tohoku Journal of Experimental Medicine, 2021, Vol.254(1), pp.49-55

2021

Volltextzugriff (PDF)

Patient perceptions of curability and physician-reported disclosures of incurability in Japanese patients with unresectable/recurrent cancer: a cross-sectional survey

Japanese journal of clinical oncology, 2018-10, Vol.48 (10), p.913-919

2018

Volltextzugriff (PDF)

Intermittent Withdrawal of Oxaliplatin for Alleviating Neurotoxicity during Oxaliplatin-Based Chemotherapy for Japanese Patients with Inoperable or Metastatic Colorectal Cancer: A Phase 2 Multicenter Study

The Tohoku Journal of Experimental Medicine, 2018, Vol.245(1), pp.21-28

2018

Volltextzugriff (PDF)

P2-027Impact of chemotherapy on overall survival and hospitalization in elderly patients with gastric cancer

Annals of oncology, 2019-10, Vol.30 (Supplement_6)

2019

Volltextzugriff (PDF)

Impact of chemotherapy on overall survival and hospitalization in elderly patients with gastric cancer

Annals of oncology, 2019-10, Vol.30, p.vi129

2019

Volltextzugriff (PDF)

The effectiveness of cancer chemotherapy among elderly patients: a retrospective study in Miyagi Cancer Center

Annals of oncology, 2018-10, Vol.29, p.vii61-vii61

2018

Volltextzugriff (PDF)

O3-3-3The effectiveness of cancer chemotherapy among elderly patients: a retrospective study in Miyagi Cancer Center

Annals of oncology, 2018-10, Vol.29 (suppl_7)

2018

Volltextzugriff (PDF)

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

The New England journal of medicine, 2020-06, Vol.382 (25), p.2419-2430

2020

Volltextzugriff (PDF)

Germ cell tumors

Nihon rinshō, 2015-02, Vol.73 Suppl 2, p.614

Murakawa, Yasuko

2015

Volltextzugriff (PDF)

The Appropriate First-Line Chemotherapy Regimen for Incurable Pancreatic Cancer in Clinical Practice: A Consideration of Patients' Overall Survival and Quality of Life

Journal of pancreatic cancer, 2021-08, Vol.7 (1), p.48-56

2021

Volltextzugriff (PDF)

Safety Verification Trials of mFOLFIRI and Sequential IRIS + Bevacizumab as First- or Second-Line Therapies for Metastatic Colorectal Cancer in Japanese Patients

Oncology, 2012, Vol.83 (2), p.101-107

2012

Volltextzugriff (PDF)

Tips on the use of granulocyte colony-stimulating factors in cancer patients predisposed to chemotherapy - induced febrile neutropenia

Gan to kagaku ryoho, 2013-06, Vol.40 (6), p.693

Murakawa, Yasuko

2013

Volltextzugriff (PDF)

A novel germline mutation of the LKB1 gene in a patient with Peutz-Jeghers syndrome with early-onset gastric cancer

Journal of gastroenterology, 2004-12, Vol.39 (12), p.1210-1214

2004

Volltextzugriff (PDF)

Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial

Anticancer research, 2022-04, Vol.42 (4), p.2009-2015

2022

Volltextzugriff (PDF)

Evaluation of Hematological Reconstitution Potential of Autologous Peripheral Blood Progenitor Cells Cryopreserved by a Simple Controlled-Rate Freezing Method

The Tohoku Journal of Experimental Medicine, 2005, Vol.205(1), pp.37-43

2005

Volltextzugriff (PDF)

Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza

Clinical infectious diseases, 2016-08, Vol.63 (3), p.330-337

2016

Volltextzugriff (PDF)

Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza

Clinical infectious diseases, 2016-08, Vol.63 (3), p.330-337

2016

Volltextzugriff (PDF)

A phase II, multicenter, open-label study of [fam-] trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing gastric cancer

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.TPS180-TPS180

2019

Volltextzugriff (PDF)

Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019-09, Vol.25 (9), p.720-726

2019

Volltextzugriff (PDF)

α-FP Normalization as a Prognostic Factor for Mediastinal Origin Embryonal Carcinoma: Report of Five Cases

Internal Medicine, 2002, Vol.41(10), pp.883-888

2002

Volltextzugriff (PDF)

The Absolute Number of Peripheral Blood CD34+ Cells Predicts a Timing for Apheresis and Progenitor Cell Yield in Patients with Hematologic Malignancies and Solid Tumors

The Tohoku Journal of Experimental Medicine, 2003, Vol.199(2), pp.111-118

2003

Volltextzugriff (PDF)

Phase II trial of cetuximab (Cmab) plus irinotecan (CPT-11) for chemorefractory Japanese patients with advanced and/or metastatic colorectal cancer (mCRC), to evaluate the efficacy and safety based on KRAS , BRAF , PIK3CA , NRAS , and AKT1 mutation status (T-CORE0801)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e14597-e14597

2013

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(46)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(22)
Male
(15)
Adult
(10)
Female
(10)
Middle Aged
(10)
Chemotherapy
(9)
General & Internal Medicine
(9)
Medicine, General & Internal
(9)
Oncology
(8)
Aged
(7)
Adolescent
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Antineoplastic Agents - Therapeutic Use
(5)
Biological And Medical Sciences
(5)
Colorectal Cancer
(5)
Gastric Cancer
(5)
Medical Sciences
(5)
Medicine, Research & Experimental
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Correlation between overall survival and quality of life in colon cancer patients with chemotherapy

Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan

Phase II Study of the Reuse of Trastuzumab with Docetaxel beyond Progression after First-Line Treatment in Second-Line Treatment for Unresectable, Metastatic Gastric Cancer (T-CORE1203)

Patient perceptions of curability and physician-reported disclosures of incurability in Japanese patients with unresectable/recurrent cancer: a cross-sectional survey

Intermittent Withdrawal of Oxaliplatin for Alleviating Neurotoxicity during Oxaliplatin-Based Chemotherapy for Japanese Patients with Inoperable or Metastatic Colorectal Cancer: A Phase 2 Multicenter Study

P2-027Impact of chemotherapy on overall survival and hospitalization in elderly patients with gastric cancer

Impact of chemotherapy on overall survival and hospitalization in elderly patients with gastric cancer

The effectiveness of cancer chemotherapy among elderly patients: a retrospective study in Miyagi Cancer Center

O3-3-3The effectiveness of cancer chemotherapy among elderly patients: a retrospective study in Miyagi Cancer Center

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

Germ cell tumors

The Appropriate First-Line Chemotherapy Regimen for Incurable Pancreatic Cancer in Clinical Practice: A Consideration of Patients' Overall Survival and Quality of Life

Safety Verification Trials of mFOLFIRI and Sequential IRIS + Bevacizumab as First- or Second-Line Therapies for Metastatic Colorectal Cancer in Japanese Patients

Tips on the use of granulocyte colony-stimulating factors in cancer patients predisposed to chemotherapy - induced febrile neutropenia

A novel germline mutation of the LKB1 gene in a patient with Peutz-Jeghers syndrome with early-onset gastric cancer

Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 Trial

Evaluation of Hematological Reconstitution Potential of Autologous Peripheral Blood Progenitor Cells Cryopreserved by a Simple Controlled-Rate Freezing Method

Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza

Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza

A phase II, multicenter, open-label study of [fam-] trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing gastric cancer

Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan

Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201

α-FP Normalization as a Prognostic Factor for Mediastinal Origin Embryonal Carcinoma: Report of Five Cases

The Absolute Number of Peripheral Blood CD34+ Cells Predicts a Timing for Apheresis and Progenitor Cell Yield in Patients with Hematologic Malignancies and Solid Tumors

Phase II trial of cetuximab (Cmab) plus irinotecan (CPT-11) for chemorefractory Japanese patients with advanced and/or metastatic colorectal cancer (mCRC), to evaluate the efficacy and safety based on KRAS , BRAF , PIK3CA , NRAS , and AKT1 mutation status (T-CORE0801)

Suchergebnisse filtern